Ratings Balaji Amines Limited NSE India S.E.

Equities

BALAMINES

INE050E01027

Market Closed - NSE India S.E. Other stock markets 12:43:53 18/06/2024 BST			5-day change	1st Jan Change
2,247 ^INR	+1.02%		+2.14%	-15.80%

05-10	Transcript : Balaji Amines Limited, Q4 2024 Earnings Call, May 10, 2024
05-08	Balaji Amines' Consolidated Profit Jumps in Fiscal Q4; Shares Surge 10%	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

The group's high margin levels account for strong profits.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's earnings growth outlook lacks momentum and is a weakness.
With an expected P/E ratio at 35.57 and 23.3 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Over the past four months, analysts' average price target has been revised downwards significantly.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-15.80%	862M	-
ECOLAB INC.	+22.61%	69.45B	A-
SIKA AG	-6.32%	45.71B	A-
GIVAUDAN SA	+24.63%	44.6B	B+
FUJIFILM HOLDINGS CORPORATION	+31.15%	27.77B	A-
EMS-CHEMIE HOLDING AG	+8.59%	19.08B	C+
SYMRISE AG	+14.61%	17.04B	B+
CELANESE CORPORATION	-10.31%	15.22B	B+
POSCO FUTURE M CO., LTD.	-26.60%	14.77B	A-
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-29.96%	12.05B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes